These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30651043)

  • 61. Scientific and Regulatory Policy Committee Best Practices: Documentation of Sexual Maturity by Microscopic Evaluation in Nonclinical Safety Studies.
    Vidal JD; Colman K; Bhaskaran M; de Rijk E; Fegley D; Halpern W; Jacob B; Kandori H; Manickam B; McKeag S; Parker GA; Regan KS; Sefing B; Thibodeau M; Vemireddi V; Werner J; Zalewska A
    Toxicol Pathol; 2021 Jul; 49(5):977-989. PubMed ID: 33661059
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.
    Ewart L; Dehne EM; Fabre K; Gibbs S; Hickman J; Hornberg E; Ingelman-Sundberg M; Jang KJ; Jones DR; Lauschke VM; Marx U; Mettetal JT; Pointon A; Williams D; Zimmermann WH; Newham P
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():65-82. PubMed ID: 29029591
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An analysis of the attrition of drug candidates from four major pharmaceutical companies.
    Waring MJ; Arrowsmith J; Leach AR; Leeson PD; Mandrell S; Owen RM; Pairaudeau G; Pennie WD; Pickett SD; Wang J; Wallace O; Weir A
    Nat Rev Drug Discov; 2015 Jul; 14(7):475-86. PubMed ID: 26091267
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Model-based drug discovery: implementation and impact.
    Visser SA; Aurell M; Jones RD; Schuck VJ; Egnell AC; Peters SA; Brynne L; Yates JW; Jansson-Löfmark R; Tan B; Cooke M; Barry ST; Hughes A; Bredberg U
    Drug Discov Today; 2013 Aug; 18(15-16):764-75. PubMed ID: 23726890
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Microarray-Based Gene Expression Analysis for Veterinary Pathologists: A Review.
    Raddatz BB; Spitzbarth I; Matheis KA; Kalkuhl A; Deschl U; Baumgärtner W; Ulrich R
    Vet Pathol; 2017 Sep; 54(5):734-755. PubMed ID: 28641485
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Optimizing the discovery organization for innovation.
    Sams-Dodd F
    Drug Discov Today; 2005 Aug; 10(15):1049-56. PubMed ID: 16055021
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Challenges of developing and validating immunogenicity assays to support comparability studies for biosimilar drug development.
    Cai XY; Thomas J; Cullen C; Gouty D
    Bioanalysis; 2012 Sep; 4(17):2169-77. PubMed ID: 23013399
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Pharmacokinetic research in the early stages of drug discovery-significance and practice].
    Shimada K
    Nihon Yakurigaku Zasshi; 2009 Apr; 133(4):210-3. PubMed ID: 19367023
    [No Abstract]   [Full Text] [Related]  

  • 69. Complex In Vitro Model Characterization for Context of Use in Toxicologic Pathology: Use Cases by Collaborative Teams of Biologists, Bioengineers, and Pathologists.
    Stokar-Regenscheit N; Bell L; Berridge B; Rudmann D; Tagle D; Hargrove-Grimes P; Schaudien D; Hahn K; Kühnlenz J; Ashton RS; Tseng M; Reichelt M; Laing ST; Kiyota T; Chamanza R; Sura R; Tomlinson L
    Toxicol Pathol; 2024 Feb; 52(2-3):123-137. PubMed ID: 38888280
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assay Guidance Manual: Quantitative Biology and Pharmacology in Preclinical Drug Discovery.
    Coussens NP; Sittampalam GS; Guha R; Brimacombe K; Grossman A; Chung TDY; Weidner JR; Riss T; Trask OJ; Auld D; Dahlin JL; Devanaryan V; Foley TL; McGee J; Kahl SD; Kales SC; Arkin M; Baell J; Bejcek B; Gal-Edd N; Glicksman M; Haas JV; Iversen PW; Hoeppner M; Lathrop S; Sayers E; Liu H; Trawick B; McVey J; Lemmon VP; Li Z; McManus O; Minor L; Napper A; Wildey MJ; Pacifici R; Chin WW; Xia M; Xu X; Lal-Nag M; Hall MD; Michael S; Inglese J; Simeonov A; Austin CP
    Clin Transl Sci; 2018 Sep; 11(5):461-470. PubMed ID: 29877628
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Advancing the drug discovery ecosystem for innovative medicines].
    Ii M; Tanaka T
    Nihon Yakurigaku Zasshi; 2024; 159(4):235-240. PubMed ID: 38945907
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative Medicine: An Inclusive Crossover Discipline.
    Macy J; Horvath TL
    Yale J Biol Med; 2017 Sep; 90(3):493-498. PubMed ID: 28955187
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Integrating diagnostics and therapeutics: revolutionizing drug discovery and patient care.
    Ross JS; Ginsburg GS
    Drug Discov Today; 2002 Aug; 7(16):859-64. PubMed ID: 12546952
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Female Presidents of the "Royal College of Pathologists": Their Achievements and Contributions.
    Coupland SE; Sandle LN; Osborn M
    Front Med (Lausanne); 2022; 9():861909. PubMed ID: 35463030
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Comparative pathology in oncology-Best practice].
    Groll T; Aupperle-Lellbach H; Mogler C; Steiger K
    Pathologie (Heidelb); 2024 May; 45(3):190-197. PubMed ID: 38602524
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drug discovery and development: Role of basic biological research.
    Mohs RC; Greig NH
    Alzheimers Dement (N Y); 2017 Nov; 3(4):651-657. PubMed ID: 29255791
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assessing the translatability of drug projects: what needs to be scored to predict success?
    Wehling M
    Nat Rev Drug Discov; 2009 Jul; 8(7):541-6. PubMed ID: 19543224
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Natural Alternatives for Chemicals Used in Histopathology Lab- A Literature Review.
    Ramamoorthy A; Ravi S; Jeddy N; Thangavelu R; Janardhanan S
    J Clin Diagn Res; 2016 Nov; 10(11):EE01-EE04. PubMed ID: 28050388
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Situated experimental agents for scientific discovery.
    Stanton SC
    Sci Robot; 2018 Nov; 3(24):. PubMed ID: 33141712
    [No Abstract]   [Full Text] [Related]  

  • 80. Evolving the Role of Discovery-focused Pathologists and Comparative Scientists in the Pharmaceutical Industry.
    Mohanan S; Maguire S; Klapwijk J; Adler R; Haworth R; Clements P
    Toxicol Pathol; 2019 Feb; 47(2):121-128. PubMed ID: 30651043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.